Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists.

Petzer JP, Steyn S, Castagnoli KP, Chen JF, Schwarzschild MA, Van der Schyf CJ, Castagnoli N.

Bioorg Med Chem. 2003 Apr 3;11(7):1299-310.

PMID:
12628657
2.

Neuroprotection in the MPTP Parkinsonian C57BL/6 mouse model by a compound isolated from tobacco.

Castagnoli KP, Steyn SJ, Petzer JP, Van der Schyf CJ, Castagnoli N Jr.

Chem Res Toxicol. 2001 May;14(5):523-7.

PMID:
11368550
3.

Enzyme-catalyzed bioactivation of cyclic tertiary amines to form potential neurotoxins.

Castagnoli N Jr, Castagnoli KP, Van der Schyf CJ, Usuki E, Igarashi K, Steyn SJ, Riker RR.

Pol J Pharmacol. 1999 Jan-Feb;51(1):31-8. Review.

PMID:
10389142
4.

Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes.

Castagnoli N Jr, Rimoldi JM, Bloomquist J, Castagnoli KP.

Chem Res Toxicol. 1997 Sep;10(9):924-40. Review.

PMID:
9305573
5.

Metabolic bioactivation reactions potentially related to drug toxicities.

Castagnoli N Jr, Castagnoli KP.

NIDA Res Monogr. 1997;173:85-105. Review. No abstract available.

PMID:
9260185
6.

Synthesis and monoamine oxidase B catalyzed oxidation of C-4 heteroaromatic substituted 1,2,3,6-tetrahydropyridine derivatives.

Nimkar SK, Anderson AH, Rimoldi JM, Stanton M, Castagnoli KP, Mabic S, Wang YX, Castagnoli N Jr.

Chem Res Toxicol. 1996 Sep;9(6):1013-22.

PMID:
8870990
7.

The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat.

Khuenl-Brady K, Castagnoli KP, Canfell PC, Caldwell JE, Agoston S, Miller RD.

Anesthesiology. 1990 Apr;72(4):669-74.

PMID:
1969717
8.

The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide.

Caldwell JE, Canfell PC, Castagnoli KP, Lynam DP, Fahey MR, Fisher DM, Miller RD.

Anesthesiology. 1989 Jan;70(1):7-12.

PMID:
2536254
9.

Pipecuronium and pancuronium: comparison of pharmacokinetics and duration of action.

Caldwell JE, Castagnoli KP, Canfell PC, Fahey MR, Lynam DP, Fisher DM, Miller RD.

Br J Anaesth. 1988 Dec;61(6):693-7.

10.

The pharmacodynamics and pharmacokinetics of vecuronium in patients anesthetized with isoflurane with normal renal function or with renal failure.

Lynam DP, Cronnelly R, Castagnoli KP, Canfell PC, Caldwell J, Arden J, Miller RD.

Anesthesiology. 1988 Aug;69(2):227-31.

PMID:
2900610
12.

Vecuronium in alcoholic liver disease: a pharmacokinetic and pharmacodynamic analysis.

Arden JR, Lynam DP, Castagnoli KP, Canfell PC, Cannon JC, Miller RD.

Anesthesiology. 1988 May;68(5):771-6.

PMID:
2897176
13.

Continuous infusion of vecuronium: the effect of anesthetic agents.

Cannon JE, Fahey MR, Castagnoli KP, Furuta T, Canfell PC, Sharma M, Miller RD.

Anesthesiology. 1987 Oct;67(4):503-6.

PMID:
2889403
14.

Pancuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly adults.

Rupp SM, Castagnoli KP, Fisher DM, Miller RD.

Anesthesiology. 1987 Jul;67(1):45-9.

PMID:
2886080
15.

Quantitative estimation of quaternary ammonium neuromuscular blocking agents in serum by direct insertion probe chemical ionization mass spectrometry.

Castagnoli KP, Shinohara Y, Furuta T, Nguyen TL, Gruenke LD, Miller RD, Castagnoli N Jr.

Biomed Environ Mass Spectrom. 1986 Jul;13(7):327-32.

PMID:
2874852
16.

Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Chiba K, Peterson LA, Castagnoli KP, Trevor AJ, Castagnoli N Jr.

Drug Metab Dispos. 1985 May-Jun;13(3):342-7.

PMID:
2861994

Supplemental Content

Loading ...
Support Center